| |
| |
|
| Insider
Information: |
Proehl Gerald T |
| Relationship: |
President, CEO and Cha... |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
149,394 |
|
|
Indirect Shares
|
3,120,953 |
|
|
| Direct
Value |
$29,766 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
3,270,347 |
|
|
| Total
Value |
$29,766 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Santarus Inc |
SNTS |
President & CEO, Direc... |
2014-01-02 |
0 |
2014-01-02 |
0 |
Premium* |
|
|
Sophiris Bio Inc. |
SPHS |
Director |
2014-09-19 |
10,000 |
2014-09-19 |
0 |
Premium* |
|
|
Auspex Pharmaceuticals, Inc. |
ASPX |
Director |
2015-05-05 |
0 |
2014-09-19 |
0 |
Premium* |
|
|
Qualigen Therapeutics Inc |
QLGN |
Director |
2015-06-24 |
50,000 |
2015-06-24 |
0 |
Premium* |
|
|
Tenax Therapeutics Inc |
TENX |
Director |
2016-11-23 |
29,882 |
2016-11-22 |
0 |
Premium* |
|
|
Dermata Therapeutics, Inc. |
DRMA |
President, CEO and Cha... |
2021-11-23 |
59,512 |
2021-11-23 |
3,120,953 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DRMA |
Dermata Therapeutics, Inc... |
President, CEO and Chairman |
• • • |
2021-11-23 |
4 |
B |
$2.40 |
$48,000 |
D/D |
20,000 |
59,512 |
3.23 |
- |
|
| DRMA |
Dermata Therapeutics, Inc... |
President, CEO and Chairman |
• • • |
2021-08-17 |
4 |
B |
$0.00 |
$0 |
I/I |
142,857 |
152,857 |
2.56 |
- |
|
| DRMA |
Dermata Therapeutics, Inc... |
President, CEO and Chairman |
• • • |
2021-08-17 |
4 |
A |
$0.00 |
$0 |
I/I |
2,050,779 |
2,905,544 |
0 |
- |
|
| DRMA |
Dermata Therapeutics, Inc... |
President, CEO and Chairman |
• • • |
2021-08-16 |
4 |
B |
$4.96 |
$49,631 |
I/I |
10,000 |
10,000 |
2.64 |
- |
|
| DRMA |
Dermata Therapeutics, Inc... |
Pres., CEO and ChairmanOfficer |
• – • |
2021-08-12 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
917,317 |
|
- |
|
| DRMA |
Dermata Therapeutics, Inc... |
Pres., CEO and ChairmanOfficer |
• – • |
2021-08-12 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
39,512 |
|
- |
|
| TENX |
Tenax Therapeutics Inc |
Director |
• • – |
2016-11-23 |
4 |
B |
$1.76 |
$25,430 |
D/D |
14,449 |
29,882 |
2.39 |
- |
|
| TENX |
Tenax Therapeutics Inc |
Director |
• • – |
2016-11-22 |
4 |
B |
$1.59 |
$24,538 |
D/D |
15,433 |
15,433 |
2.39 |
- |
|
| QLGN |
Qualigen Therapeutics Inc |
Director |
– • – |
2015-06-24 |
4 |
B |
$5.00 |
$250,000 |
D/D |
50,000 |
50,000 |
2.39 |
- |
|
| ASPX |
Auspex Pharmaceuticals, I... |
Director |
– • – |
2015-05-05 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,466) |
0 |
0 |
- |
|
| ASPX |
Auspex Pharmaceuticals, I... |
Director |
– • – |
2014-09-19 |
4 |
B |
$21.75 |
$31,885 |
D/D |
1,466 |
1,466 |
2.39 |
- |
|
| SPHS |
Sophiris Bio Inc. |
Director |
– • – |
2014-09-19 |
4 |
B |
$3.16 |
$31,599 |
D/D |
10,000 |
10,000 |
2.39 |
- |
|
| SNTS |
Santarus Inc |
President & CEO |
• • – |
2014-01-02 |
4 |
A |
$1.18 |
$999,996 |
D/D |
233,341 |
263,879 |
0 |
- |
|
| SNTS |
Santarus Inc |
President & CEO |
• • – |
2014-01-02 |
4 |
D |
$32.00 |
$9,537,056 |
I/I |
(298,033) |
0 |
0 |
- |
|
| SNTS |
Santarus Inc |
President & CEO |
• • – |
2014-01-02 |
4 |
D |
$32.00 |
$7,466,912 |
D/D |
(233,341) |
30,538 |
0 |
- |
|
| SNTS |
Santarus Inc |
President & CEO |
• • – |
2014-01-02 |
4 |
D |
$32.00 |
$977,216 |
D/D |
(30,538) |
0 |
0 |
- |
|
| SNTS |
Santarus Inc |
President & CEO |
• • – |
2014-01-02 |
4 |
D |
$32.00 |
$999,968 |
I/I |
(31,249) |
298,033 |
0 |
- |
|
| SNTS |
Santarus Inc |
President & CEO |
• • – |
2013-12-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
56,643 |
30,538 |
0 |
- |
|
| SNTS |
Santarus Inc |
President & CEO |
• • – |
2013-12-16 |
4 |
OE |
$3.50 |
$198,251 |
D/D |
56,643 |
87,181 |
0 |
- |
|
| SNTS |
Santarus Inc |
President & CEO |
• • – |
2013-12-16 |
4 |
GA |
$0.00 |
$0 |
I/I |
56,643 |
385,925 |
0 |
- |
|
| SNTS |
Santarus Inc |
President & CEO |
• • – |
2013-12-16 |
4 |
AS |
$31.95 |
$1,809,461 |
I/I |
(56,643) |
329,282 |
0 |
- |
|
| SNTS |
Santarus Inc |
President & CEO |
• • – |
2013-11-15 |
4 |
AS |
$32.02 |
$1,813,707 |
I/I |
(56,644) |
329,282 |
0 |
- |
|
| SNTS |
Santarus Inc |
President & CEO |
• • – |
2013-11-15 |
4 |
GA |
$0.00 |
$0 |
I/I |
56,644 |
385,926 |
0 |
- |
|
| SNTS |
Santarus Inc |
President & CEO |
• • – |
2013-11-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
56,644 |
30,190 |
0 |
- |
|
| SNTS |
Santarus Inc |
President & CEO |
• • – |
2013-11-15 |
4 |
OE |
$3.50 |
$198,254 |
D/D |
56,644 |
86,834 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
